Abound Wealth Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74K Buy
172
+9
+6% +$139 ﹤0.01% 708
2026
Q1
$2.21K Hold
163
﹤0.01% 889
2025
Q4
$2.04K Buy
163
+55
+51% +$593 ﹤0.01% 846
2025
Q3
$1.07K Buy
108
+1
+0.9% +$10 ﹤0.01% 866
2025
Q2
$956 Buy
107
+51
+91% +$431 ﹤0.01% 808
2025
Q1
$488 Hold
56
﹤0.01% 821
2024
Q4
$698 Hold
56
﹤0.01% 764
2024
Q3
$651 Hold
56
﹤0.01% 819
2024
Q2
$596 Hold
56
﹤0.01% 779
2024
Q1
$669 Hold
56
﹤0.01% 824
2023
Q4
$607 Hold
56
﹤0.01% 876
2023
Q3
$553 Hold
56
﹤0.01% 783
2023
Q2
$559 Sell
56
-16
-22% -$153 ﹤0.01% 811
2023
Q1
$693 Buy
72
+16
+29% +$177 ﹤0.01% 654
2022
Q4
$624 Hold
56
﹤0.01% 646
2022
Q3
$478 Buy
+56
New +$551 ﹤0.01% 663

Other funds holding VTRS

Abound Wealth Management's VTRS Position: Q2 2026 in Review

Abound Wealth Management increased its Viatris (VTRS) stake by 5.5% in Q2 2026, buying an estimated $139 and bringing the position to 172 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Abound Wealth Management first reported a position in VTRS in Q3 2022 and has held it in 16 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Abound Wealth Management held 172 shares of Viatris worth $2.74K as of Q2 2026.
  • Abound Wealth Management bought 9 Viatris shares in Q2 2026, an estimated $139.
  • Viatris made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #708 holding.
  • Abound Wealth Management first reported a position in Viatris in Q3 2022 and has held it in 16 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.